Terms: = Kidney tumors AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
14 results:
1. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
[TBL] [Abstract] [Full Text] [Related]
2. Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal tumors: 25-Year Experience in a Single Institution.
Park SJ; Park JS; Lee CS; Kang BJ; Jung CW
Clin Orthop Surg; 2023 Feb; 15(1):109-117. PubMed ID: 36778984
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang N; Qin Y; Du F; Wang X; Song C
Gene; 2022 Aug; 834():146638. PubMed ID: 35680019
[TBL] [Abstract] [Full Text] [Related]
4. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database.
Wang J; Tang J; Liu X; He D
BMC Urol; 2022 May; 22(1):78. PubMed ID: 35610606
[TBL] [Abstract] [Full Text] [Related]
5. The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study.
Guven DC; Acar R; Yekeduz E; Bilgetekin I; Baytemur NK; Erol C; Ceylan F; Sendur MA; Demirci U; Urun Y; Karadurmus N; Erman M; Kilickap S
Curr Probl Cancer; 2021 Dec; 45(6):100760. PubMed ID: 34130864
[TBL] [Abstract] [Full Text] [Related]
6. [Segmental vena cava resection for the treatment of renal tumor with invading tumor thrombus].
Ye JF; Ma LL; Zhao L; Wang GL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):183-187. PubMed ID: 29483744
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical treatment.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
Medicine (Baltimore); 2016 Jan; 95(4):e2626. PubMed ID: 26825920
[TBL] [Abstract] [Full Text] [Related]
8. Longitudinal Changes in Body Composition in Patients After Initiation of Hemodialysis Therapy: Results From an International Cohort.
Marcelli D; Brand K; Ponce P; Milkowski A; Marelli C; Ok E; Merello Godino JI; Gurevich K; Jirka T; Rosenberger J; Di Benedetto A; Ladányi E; Grassmann A; Scatizzi L; Bayh I; Kooman J; Canaud B
J Ren Nutr; 2016 Mar; 26(2):72-80. PubMed ID: 26627050
[TBL] [Abstract] [Full Text] [Related]
9. Trends in Metastatic kidney Cancer Survival From the Cytokine to the Targeted Therapy Era.
Macleod LC; Tykodi SS; Holt SK; Wright JL; Lin DW; Tretiakova MS; True LD; Gore JL
Urology; 2015 Aug; 86(2):262-8. PubMed ID: 26199164
[TBL] [Abstract] [Full Text] [Related]
10. [Bilateral metastases of renal cell carcinoma to the ovaries--a case report].
Hołody-Zareba J; Kinalski P; Sulkowski S; Kozłowski R; Kinalski M
Ginekol Pol; 2013 Jul; 84(7):650-3. PubMed ID: 24032280
[TBL] [Abstract] [Full Text] [Related]
11. Bilateral synchronous sporadic renal masses: intermediate functional and oncological outcomes at a single institution.
Woodson B; Fernandez R; Stewart C; Mandava S; Wang L; Lee BR
Int Urol Nephrol; 2013 Jun; 45(3):619-25. PubMed ID: 23529271
[TBL] [Abstract] [Full Text] [Related]
12. Association between prostate cancer and urinary calculi: a population-based study.
Chung SD; Liu SP; Lin HC
PLoS One; 2013; 8(2):e57743. PubMed ID: 23451265
[TBL] [Abstract] [Full Text] [Related]
13. Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisal.
Kilonzo M; Hislop J; Elders A; Fraser C; Bissett D; McClinton S; Mowatt G; Vale L
Pharmacoeconomics; 2013 Jan; 31(1):15-24. PubMed ID: 23329590
[TBL] [Abstract] [Full Text] [Related]
14. Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.
Donadio C; Lucchesi A; Ardini M; Cosio S; Fanucchi A; Gadducci A
Ther Drug Monit; 2009 Feb; 31(1):63-9. PubMed ID: 19077927
[TBL] [Abstract] [Full Text] [Related]
